Herpes Simplex Virus-1 (HSV1) IgG

 The HSV-1 IgG serum test detects antibodies specific to the herpes simplex virus type 1 in the blood. IgG antibodies typically develop several weeks after infection and remain in the body for life, indicating past exposure to the virus, which commonly causes cold sores and oral herpes.

The test is performed to determine whether a person has been previously infected with HSV-1. It is often used in prenatal screening, prior to organ transplantation, or in patients with suspected recurrent oral or facial herpes to assess immune status and guide preventive or therapeutic strategies.

A blood sample is collected and tested using enzyme-linked immunosorbent assay (ELISA) or chemiluminescent immunoassays. These tests are designed to detect the presence of IgG antibodies against HSV-1 with high sensitivity and specificity.

A positive result indicates that the person has been exposed to HSV-1 at some point and has developed antibodies against it. This does not necessarily mean there is an active infection. The presence of antibodies suggests immunity but does not rule out the possibility of virus reactivation or transmission.

Yes, type-specific assays are designed to distinguish between HSV-1 and HSV-2 antibodies. This distinction is important because HSV-1 is primarily associated with oral lesions, while HSV-2 is more commonly linked to genital herpes. Accurate differentiation aids in clinical counseling and management.